Pazopanib is a pyrimidine that is 5-(pyrimidin-2-yl}amino-2-methylbenzenesulfonamide substituted at position 4 by a (2,3-dimethylindazol-6-yl)(methyl)amino group. Used as its hydrochloride salt for treatment of kidney cancer. It is grouped under the following drug class(es): Kinase inhibitors and VEGF inhibitors. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Votrient and indazolylpyrimidine 13. Its PubChem CID is 10113978.
Pazopanib
| CAS No | 444731-52-6 |
|---|---|
| Molecular Formula | C21H23N7O2S |
| Molecular Weight | 437.5 g/mol |
| Synonyms | 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pazopanib is a pyrimidine that is 5-(pyrimidin-2-yl}amino-2-methylbenzenesulfonamide substituted at position 4 by a (2,3-dimethylindazol-6-yl)(methyl)amino group.
The listed CAS number is 444731-52-6.
The listed molecular formula is C21H23N7O2S.
The listed molecular weight is 437.5 g/mol.
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide.
The source lists Votrient and indazolylpyrimidine 13.